Rolf A. Stahel - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Rolf A. Stahel's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Rolf A. Stahel

Rolf A. Stahel

Verified

Editor in Chief, Lung Cancer

Final Covers

Body Image WellnessHealth Women's Health

Doesn’t Cover

religion, entertainment, sports

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 4

  • Dr. Stahel on Treatment Sequencing in Stage IV NSCLC

    By Rolf A. Stahel| OncLive Verified Rolf A. Stahel, MD, professor in the oncology clinic, University Hospital, Zurich, discusses treatment sequencing in stage IV non–small cell lung cancer (NSCLC). The interview with OncLive was conducted at the 2019 European Lung Cancer Congress in Geneva, Switzerland. Over the last few years, sequencing in advanced NSCLC has changed, Stahel says. It was a generally simple paradigm a few years ago of frontline chemotherapy followed by an alternative chemotherapy agent in the second-line setting

    By Rolf A. Stahel · OncLive

    May. 03, 2019

  • PD-1 blockade in advanced NSCLC: a focus on pembrolizumab

    By Solange Peters, Rolf A. Stahel, Keith M Kerr, Switzerland Zürich| Cancer Treatment Reviews Verified Publication HistoryPublished online: October 23, 2017Accepted: October 15, 2017; Received: October 5, 2017;

    By Solange Peters, Rolf A. Stahel, Keith M Kerr, Switzerland Zürich · Cancer Treatment Reviews

    Oct. 23, 2017

As seen in

Company Info

Lung Cancer

Zurich, Zurich, Switzerland

+41 44 255 11 11